The Role of PSMA PET Imaging in Prostate Cancer Theranostics: A Nationwide Survey
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
Online-Ressource
- Language
-
Englisch
- Bibliographic citation
-
In: 10.1159/000526598
- Event
-
Veröffentlichung
- (where)
-
Aachen
- (who)
-
Universitätsbibliothek der RWTH Aachen
- (when)
-
2022
- Creator
-
Borkowetz, Angelika
Linxweiler, Johannes
Fussek, Sebastian
Wullich, Bernd
Saar, Matthias
- DOI
-
10.18154/RWTH-CONV-250164
- URN
-
urn:nbn:de:101:1-2023020301341720445706
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
25.03.2025, 1:47 PM CET
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Borkowetz, Angelika
- Linxweiler, Johannes
- Fussek, Sebastian
- Wullich, Bernd
- Saar, Matthias
- Universitätsbibliothek der RWTH Aachen
Time of origin
- 2022
Other Objects (12)
The Role of PSMA PET Imaging in Prostate Cancer Theranostics : A Nationwide Survey
Inhibitors of the prostate-specific membrane antigen (PSMA) for PET imaging and endoradiotherapy of prostate cancer
Editorial: Exploring the potential of PSMA-PET imaging on personalized prostate cancer treatment
PSMA PET/CT : joint EANM procedure guideline/SNMMI procedure standard for prostate cancer imaging 2.0
The PSMA-11-derived hybrid molecule PSMA-914 specifically identifies prostate cancer by preoperative PET/CT and intraoperative fluorescence imaging
⁶⁸Ga-PSMA PET for the assessment of metastatic prostate cancer
A simple approach to 18F-labeled PSMA-selective ligands for PET imaging of prostate cancer recurrence
[68Ga]Ga-PSMA-11: The First FDA-Approved 68Ga-Radiopharmaceutical for PET Imaging of Prostate Cancer
Effect of point-spread function reconstruction for indeterminate PSMA-RADS-3A lesions on PSMA-targeted PET imaging of men with prostate cancer
68Ga-PSMA I&T PET/CT for primary staging of prostate cancer
68Ga-PSMA I&T PET/CT for primary staging of prostate cancer [Abstract]
68Ga-PSMA-PET/CT in patients with biochemical prostate cancer recurrence and negative 18F-choline-PET/CT
The Role of PSMA PET Imaging in Prostate Cancer Theranostics : A Nationwide Survey
Inhibitors of the prostate-specific membrane antigen (PSMA) for PET imaging and endoradiotherapy of prostate cancer
Editorial: Exploring the potential of PSMA-PET imaging on personalized prostate cancer treatment
PSMA PET/CT : joint EANM procedure guideline/SNMMI procedure standard for prostate cancer imaging 2.0
The PSMA-11-derived hybrid molecule PSMA-914 specifically identifies prostate cancer by preoperative PET/CT and intraoperative fluorescence imaging
⁶⁸Ga-PSMA PET for the assessment of metastatic prostate cancer
A simple approach to 18F-labeled PSMA-selective ligands for PET imaging of prostate cancer recurrence
[68Ga]Ga-PSMA-11: The First FDA-Approved 68Ga-Radiopharmaceutical for PET Imaging of Prostate Cancer
Effect of point-spread function reconstruction for indeterminate PSMA-RADS-3A lesions on PSMA-targeted PET imaging of men with prostate cancer
68Ga-PSMA I&T PET/CT for primary staging of prostate cancer
68Ga-PSMA I&T PET/CT for primary staging of prostate cancer [Abstract]
68Ga-PSMA-PET/CT in patients with biochemical prostate cancer recurrence and negative 18F-choline-PET/CT
The Role of PSMA PET Imaging in Prostate Cancer Theranostics : A Nationwide Survey
Inhibitors of the prostate-specific membrane antigen (PSMA) for PET imaging and endoradiotherapy of prostate cancer
Editorial: Exploring the potential of PSMA-PET imaging on personalized prostate cancer treatment
PSMA PET/CT : joint EANM procedure guideline/SNMMI procedure standard for prostate cancer imaging 2.0
The PSMA-11-derived hybrid molecule PSMA-914 specifically identifies prostate cancer by preoperative PET/CT and intraoperative fluorescence imaging
⁶⁸Ga-PSMA PET for the assessment of metastatic prostate cancer
A simple approach to 18F-labeled PSMA-selective ligands for PET imaging of prostate cancer recurrence
[68Ga]Ga-PSMA-11: The First FDA-Approved 68Ga-Radiopharmaceutical for PET Imaging of Prostate Cancer
Effect of point-spread function reconstruction for indeterminate PSMA-RADS-3A lesions on PSMA-targeted PET imaging of men with prostate cancer
68Ga-PSMA I&T PET/CT for primary staging of prostate cancer
68Ga-PSMA I&T PET/CT for primary staging of prostate cancer [Abstract]